The mutant selection window in rabbits infected with Staphylococcus aureus.
about
Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionCan we prevent antimicrobial resistance by using antimicrobials better?Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and ValnemulinDoes High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamicsMutant selection window and characterization of allelic diversity for ciprofloxacin-resistant mutants of Rhodococcus equi.In vitro system for modeling influenza A virus resistance under drug pressureEvaluation of meropenem regimens suppressing emergence of resistance in Acinetobacter baumannii with human simulated exposure in an in vitro intravenous-infusion hollow-fiber infection model.In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureusIn vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.Mutant selection window hypothesis updated.Optimizing drug exposure to minimize selection of antibiotic resistance.Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.A unified anti-mutant dosing strategy.Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection modelQuinolones: action and resistance updated.Emergence and spread of antibiotic resistance following exposure to antibiotics.Susceptibility and PK/PD relationships of Staphylococcus aureus strains from ovine and caprine with clinical mastitis against five veterinary fluoroquinolones.Experimental Simulation of the Effects of an Initial Antibiotic Treatment on a Subsequent Treatment after Initial Therapy Failure.In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin.Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infectionInfluence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure.Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.Suppression of reactive-oxygen-species accumulation accounts for paradoxical bacterial survival at high quinolone concentration.Modeling the emergence of antibiotic resistance in the environment: an analytical solution for the minimum selection concentration.Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius.Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used.Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics.Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model.Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of After Repeated Administration of Danofloxacin
P2860
Q26753831-00E7CA1E-BEA3-498A-BCEB-F3514E7F9AFEQ26829707-C349FF89-C78C-4F7F-82A9-C3F5B9E8163CQ28468397-86D6C9C5-3A20-4C9B-A801-1F2F9A09111CQ28552950-AD111FC5-422D-4AAA-992B-71B6442A481AQ30911044-03B14555-217C-419B-A577-E2FF77C92DD1Q33876556-E8C76FA2-0086-471F-981B-FA1BEEC6FC2CQ34045286-E34E0EAF-779E-4E45-B869-9465E2BCAAAFQ34045479-B3009A48-C074-48DB-AB7F-4BD809E7E7E0Q34596344-348F49EC-550A-4F20-97B6-F58ABFCA1DD0Q34788573-C0012D3C-920D-4ACC-B929-3B7F83AA9A66Q34932274-71202354-33D1-46BB-940B-02CB9DA8CB1EQ35884208-642B1EBA-F523-488C-9469-2853C2BDFD04Q36728061-5140672A-97DC-4999-9A0E-27D744F0EDBBQ36903693-43E727E9-0651-411E-8880-0197DF1690FFQ36976649-5A8E5A61-1391-435B-BE11-CC35AD2330FAQ37188136-16B0AD30-529D-496B-BBE1-0FD907D105A3Q37191156-EF38D353-6704-4B30-8695-1985E1266FB4Q37274635-945BE2C0-BFCB-49F8-A2B6-B4C7F12DE89BQ37595559-6F174808-1EAF-4937-9891-5AD293757438Q37896674-E7A76C89-3184-4FB2-9468-06702DD6E46BQ38954542-2C948017-E663-4F6A-A1B2-39C010519D9BQ38977198-89D5D9BD-1E37-4072-8971-2DF1612B3B70Q40220956-8907F4AC-C0E8-421B-9032-A3360D660886Q40499211-FB220C83-B13C-429C-9089-ACA0C71C6B14Q41648730-455881FE-6942-4999-ADF4-0BBE7EE6965DQ41785898-A7D4F391-4EC4-43C7-BB42-FDE5B568E2EAQ41850136-3C6465A7-DFF2-4DD5-AE61-5B3A97BFF5B7Q41913615-663D6EBA-F4FF-48C3-AD2E-96EBFCBFE9BCQ42612081-CF11DE1E-E327-46D2-93A1-562AD37C9049Q42947152-95B977DA-AE3B-43E9-9DA1-A7EEE9B7260EQ43243027-4A7FF5B4-13AE-4E17-8A85-FE5BDAEEF36EQ43988363-75F70921-BDDD-4ADC-A944-A4C0E7DB0BE3Q46243490-19A27B55-9E35-4B71-864B-0FC33D4E6716Q47273948-6266DF39-7F57-4A1D-9156-131F29C39B82Q48030921-DD59E999-D511-469D-973A-17F4A12E8F41Q48575528-1D5AF0BB-75D1-47DE-978C-34EB4B57B77BQ49578631-7F10254C-1633-45E9-915C-4868D5E8D7B7Q52655481-28FC18CF-6859-4C94-BA8A-154AF62A131DQ54187518-1CA91E84-3FC1-496F-981E-BE2E389A1FD6Q58123039-2D28F4B1-4D5E-40CF-A20F-59E7AFF86460
P2860
The mutant selection window in rabbits infected with Staphylococcus aureus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
The mutant selection window in rabbits infected with Staphylococcus aureus.
@en
The mutant selection window in rabbits infected with Staphylococcus aureus.
@nl
type
label
The mutant selection window in rabbits infected with Staphylococcus aureus.
@en
The mutant selection window in rabbits infected with Staphylococcus aureus.
@nl
prefLabel
The mutant selection window in rabbits infected with Staphylococcus aureus.
@en
The mutant selection window in rabbits infected with Staphylococcus aureus.
@nl
P2093
P356
P1476
The mutant selection window in rabbits infected with Staphylococcus aureus.
@en
P2093
Junchang Cui
Karl Drlica
Weihang Tong
Youning Liu
P304
P356
10.1086/508752
P407
P50
P577
2006-10-20T00:00:00Z